Journal of Urologic Oncology

Editorial

March 31, 2025

Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick

Cheol Kwak

J Urol Oncol. 2025;23(1):1-3.

Invited Review

March 31, 2025

Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review

Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman

J Urol Oncol. 2025;23(1):4-13.

Precision oncology offers a transformative approach to managing localized prostate cancer (PCa) by tailoring interventions to the biological characteristics of the disease. This strategy addresses critical challenges such as overdiagnosis,...

Original Article

March 31, 2025

The Clinical Impact of Depression and Anxiety on Complications After Prostate Cancer Treatment: A Retrospective Cohort Study

Elliott J. Druten, Will P. Hoover, Jacob Bardell, et al.

J Urol Oncol. 2025;23(1):14-19.

Purpose: This large retrospective study aims to better understand the relationship of depression and anxiety with posttreatment complications in prostate cancer patients, specifically erectile dysfunction (ED) and urinary incontinence. Materials and...

Original Article

March 31, 2025

A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients

Hyunho Han, Ik Jae Lee, Woong Sub Koom, et al.

J Urol Oncol. 2025;23(1):20-29.

Purpose: To evaluate the placement accuracy and learning curve of SpaceOAR hydrogel and gold fiducial marker insertion in Korean prostate cancer patients undergoing carbon ion radiotherapy (CIRT), performed by a...

Original Article

March 31, 2025

Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy

Hyun Jung Lee, Won Hoon Song, Seung Soo Lee, et al.

J Urol Oncol. 2025;23(1):30-37.

Purpose: The extent of seminal vesicle invasion (SVI) in prostate cancer can be classified into muscle layer invasion (SVI-muscle) and mucosal layer invasion (SVI-mucosa). This study aimed to evaluate the...

Invited Review

March 31, 2025

Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma

Renpei Kato

J Urol Oncol. 2025;23(1):38-46.

Cytoreductive nephrectomy (CN) has been a pivotal consideration in the treatment of metastatic renal cell carcinoma, with its role evolving significantly in the era of immuno-oncology (IO) therapies. This review...

Original Article

March 31, 2025

Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models

Dongrul Shin, Maisy Song, Jungyo Suh, et al.

J Urol Oncol. 2025;23(1):47-53.

Purpose: Determining the optimal surgical approach for patients with T1 renal tumors requires balancing long-term oncological and renal functional outcomes. Using machine learning algorithms, we aimed to develop a model...

Original Article

March 31, 2025

Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma

Mónica Sanz del Pozo, Cristina Plaza Alonso, Álvaro Linacero Gracia, et al.

J Urol Oncol. 2025;23(1):54-62.

Purpose: The present study aimed at determining the expression of carbonic anhydrase IX (CAIX) in tissue and serum of patients with clear cell renal cell carcinoma (ccRCC) and its relationship...

Invited Review

March 31, 2025

A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation

Hye Won Lee, Hyun Hwan Sung

J Urol Oncol. 2025;23(1):63-78.

Patients diagnosed with muscle-invasive bladder cancer (MIBC) frequently exhibit a high incidence of micrometastatic disease. The current standard of care for localized MIBC involves cisplatin-based neoadjuvant chemotherapy followed by radical...

Original Article

March 31, 2025

Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study

Jiwoong Yu, Wook Nam, Kyung Hwan Kim, et al.

J Urol Oncol. 2025;23(1):79-87.

Purpose: To evaluate whether extended pelvic lymph node dissection (PLND) improves survival outcomes compared with standard PLND in patients with bladder cancer (BCa) undergoing radical cystectomy (RC), and to assess...

Original Article

March 31, 2025

Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study

Jee Soo Park, Won Sik Jang, Jieun Heo, et al.

J Urol Oncol. 2025;23(1):88-93.

Purpose: Although bladder cancer occurs three to 4 times more frequently in men than in women, the relative number of deaths compared to incidence is higher in women, suggesting that...

Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick Cheol Kwak J Urol Oncol. 2025;23(1):1-3. Editorial Mar 31, 2025 Full text PubReader ePub PDF	Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman J Urol Oncol. 2025;23(1):4-13. Cited By 1 Invited Review Mar 31, 2025 Prostate Cancer Full text PubReader ePub PDF
The Clinical Impact of Depression and Anxiety on Complications After Prostate Cancer Treatment: A Retrospective Cohort Study Elliott J. Druten, Will P. Hoover, Jacob Bardell, et al. J Urol Oncol. 2025;23(1):14-19. Cited By 1 Original Article Mar 31, 2025 Prostate Cancer Full text PubReader ePub PDF	A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients Hyunho Han, Ik Jae Lee, Woong Sub Koom, et al. J Urol Oncol. 2025;23(1):20-29. Cited By 1 Original Article Mar 31, 2025 Prostate Cancer Full text PubReader ePub PDF
Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy Hyun Jung Lee, Won Hoon Song, Seung Soo Lee, et al. J Urol Oncol. 2025;23(1):30-37. Cited By 1 Original Article Mar 31, 2025 Prostate Cancer Full text PubReader ePub PDF	Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma Renpei Kato J Urol Oncol. 2025;23(1):38-46. Cited By 1 Invited Review Mar 31, 2025 Kidney Cancer Full text PubReader ePub PDF
Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models Dongrul Shin, Maisy Song, Jungyo Suh, et al. J Urol Oncol. 2025;23(1):47-53. Cited By 1 Original Article Mar 31, 2025 Kidney Cancer Full text PubReader ePub PDF	Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma Mónica Sanz del Pozo, Cristina Plaza Alonso, Álvaro Linacero Gracia, et al. J Urol Oncol. 2025;23(1):54-62. Cited By 1 Original Article Mar 31, 2025 Kidney Cancer Full text PubReader ePub PDF
A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation Hye Won Lee, Hyun Hwan Sung J Urol Oncol. 2025;23(1):63-78. Cited By 1 Invited Review Mar 31, 2025 Bladder Cancer Full text PubReader ePub PDF	Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study Jiwoong Yu, Wook Nam, Kyung Hwan Kim, et al. J Urol Oncol. 2025;23(1):79-87. Cited By 1 Original Article Mar 31, 2025 Bladder Cancer Full text PubReader ePub PDF Supplementary Material
Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study Jee Soo Park, Won Sik Jang, Jieun Heo, et al. J Urol Oncol. 2025;23(1):88-93. Cited By 1 Original Article Mar 31, 2025 Bladder Cancer Full text PubReader ePub PDF

6,253	Complex Epidemiology of Prostate Cancer in Asian Countries
4,161	Current Update on Prostate Cancer Immunotherapy
3,992	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
3,821	Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
3,662	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades

Cited By 11	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 10	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 3	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 3	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review